Q65K (p.Gln65Lys) variant of INS (Insulin)
Q65K (p.Gln65Lys) in INS (Insulin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes population frequency data and structural context.
Q65K (p.Gln65Lys) variant details
- p.Gln65Lys
- NCI-TCGA Cosmic COSV9917
- cosmic curated COSV99171
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.361
- REVEL 0.38
- MetaLR 0.62
- MetaSVM -0.43
- CADD 6.96
- PolyPhen-2 0.19
- SIFT 0.92
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available